AquADEK ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
299	嚢胞性線維症	2

299. 嚢胞性線維症

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01859390 (ClinicalTrials.gov)	June 2013	17/5/2013	Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in C ...	A Multi-Center, Randomized, Controlled, Double-Blind Study of the Effects of an Antioxidant-Enriched ...	Cystic Fibrosis	Drug: AquADEKs-2;Dietary Supplement: control multivitamin	University of Colorado, Denver	Cystic Fibrosis Foundation Therapeutics;Yasoo Health	Completed	10 Years	N/A	All	73	Phase 2	United States
2	NCT01018303 (ClinicalTrials.gov)	August 2007	19/11/2009	Safety and Efficacy of an Antioxidant-rich Multivitamin Supplement in Cystic Fibrosis	Safety and Efficacy of a Novel Antioxidant-rich Multivitamin Supplement for Persons With Cystic Fibr ...	Cystic Fibrosis	Dietary Supplement: AquADEK	University of Colorado, Denver	Cystic Fibrosis Foundation Therapeutics;Yasoo Health;National Institutes of Health (NIH)	Completed	10 Years	40 Years	Both	17	Phase 1/Phase 2	United States

First Previous1Next Last